(1)
Gutierrez, C. L. D.; Quero-Taggaoa, A. K. H.; Uy, T. C. F.; Veloso, J. A. D. High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax. J Med Cases 2026, 17 (4), 146-152. https://doi.org/10.14740/jmc5237.